Skip to main navigation Skip to search Skip to main content

Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Angiotensin-(1-7) modulates renal blood flow in humans with essential hypertension by inducing vasodilation and counterbalancing angiotensin II-induced vasoconstriction. Little is, however, known about the effects of angiotensin-(1-7) in kidneys with atherosclerotic renal artery stenosis. We previously demonstrated that the effect of angiotensin-(1-7) is reduced in patients with increased activity of the renin-angiotensin system. As the renin-angiotensin system is also activated in kidneys with renal artery stenosis, we hypothesized that the vasodilatory effect of angiotensin-(1-7) is also reduced in such kidneys. Method: Therefore, we selectively measured mean renal blood flow (133 Xenon washout method) before and during local infusion of angiotensin-(1-7) (0.27, 0.9, and 2.7 ng/kg per min) in hypertensive patients who were angiographically evaluated for the presence of renovascular abnormalities. Data were analyzed in three groups: stenotic kidneys, nonstenotic kidneys with renal artery stenosis of the contralateral kidney (contralateral stenotic kidneys), or essentially hypertensive controls without renovascular abnormalities (matched for urinary sodium excretion). Results: Angiotensin-(1-7) infusion resulted in an increase in renal blood flow in matched controls. In stenotic kidneys however, the effect of angiotensin-(1-7) was significantly reduced as compared to controls. The angiotensin-(1-7) effect in contralateral stenotic kidneys was comparable to controls. Conclusion: Angiotensin-(1-7)-induced vasodilation is reduced in stenotic kidneys, but not in contralateral stenotic kidneys. This suggests that the altered blood flow regulation in kidneys with atherosclerotic renal artery stenosis is a local phenomenon and not related to generalized atherosclerotic burden. Probably, the renin-angiotensin system activation, bioavailability of nitric oxide, and structural changes in the stenotic kidney play a role in this phenomenon.
Original languageEnglish
Pages (from-to)2428-2432
Number of pages5
JournalJournal of Hypertension
Volume32
Issue number12
DOIs
Publication statusPublished - Dec 2014

Keywords

  • angiotensin-(1-7)
  • hypertension
  • kidney
  • renal artery stenosis
  • renin-angiotensin system

Fingerprint

Dive into the research topics of 'Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis'. Together they form a unique fingerprint.

Cite this